These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33131044)

  • 21. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis.
    Cone SJ; Fuquay AT; Litofsky JM; Dement TC; Carolan CA; Hudson NE
    Acta Biomater; 2020 Apr; 107():164-177. PubMed ID: 32105833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.
    de Vries JJ; Hoppenbrouwers T; Martinez-Torres C; Majied R; Özcan B; van Hoek M; Leebeek FWG; Rijken DC; Koenderink GH; de Maat MPM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.
    Al-Horani RA; Kar S
    Eur J Med Chem; 2020 Aug; 200():112442. PubMed ID: 32502864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.
    Anokhin BA; Dean WL; Smith KA; Flick MJ; Ariëns RAS; Philippou H; Maurer MC
    FEBS J; 2020 Feb; 287(3):452-464. PubMed ID: 31407850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
    Ząbczyk M; Natorska J; Undas A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
    Richardson VR; Cordell P; Standeven KF; Carter AM
    Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.
    Nikolajsen CL; Dyrlund TF; Poulsen ET; Enghild JJ; Scavenius C
    J Biol Chem; 2014 Mar; 289(10):6526-6534. PubMed ID: 24443567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
    Koncz Z; Bagoly Z; Haramura G; Mezei ZA; Muszbek L
    Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.
    Chang GMT; Atkinson HM; Berry LR; Chan AKC
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):431-437. PubMed ID: 27898513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biorelevant polyanions stabilize fibrin against mechanical and proteolytic decomposition: Effects of polymer size and electric charge.
    Komorowicz E; Balázs N; Tanka-Salamon A; Varga Z; Szabó L; Bóta A; Longstaff C; Kolev K
    J Mech Behav Biomed Mater; 2020 Feb; 102():103459. PubMed ID: 31604180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA
    Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way.
    Semeraro F; Ammollo CT; Semeraro N; Colucci M
    Thromb Res; 2020 Dec; 196():193-199. PubMed ID: 32891905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran.
    Ammollo CT; Semeraro N; Carratù MR; Colucci M; Semeraro F
    J Pharmacol Exp Ther; 2016 Feb; 356(2):305-13. PubMed ID: 26578266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.